Posted By: sbracken
July 16, 2020 @ 7:38 am Blogs, Covid-19
A COVID-19 vaccine being developed by the drug company Moderna in partnership with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) is moving into its next phase after
Posted By: Staff
July 14, 2020 @ 12:05 am News Daypop
U.S. health officials and drugmakers are expecting to start producing potential coronavirus vaccine doses by the end of the summer, a senior administration official said Monday. The U.S. is aiming to deliver 300 million doses of a
Posted By: sbracken
May 26, 2020 @ 6:08 am Blogs, Covid-19
The drug company Novavax, headquartered in Gaithersburg, MD, announced that it is getting $384 million in funding to develop a vaccine and is advancing clinical trials. The funding is from the Coalition for Epidemic Preparedness Innovations (CEPI)
Posted By: sbracken
May 18, 2020 @ 6:29 am Blogs, Covid-19
The drugmaker Moderna says early trial results from a possible vaccine for the novel coronavirus, which is the underlying cause of COVID-19, are positive. The phase 1 trial involved 45 healthy people, in different age groups from
The Friday morning, May 15, 2020 Johns Hopkins COVID-19 Dashboard at 6:33 a.m.: Worldwide cases: 4,498,579 Worldwide deaths: 304,631 U.S. cases: 1,426,716 U.S. deaths: 86,228 Health authorities say COVID-19 is still a serious threat,
Posted By: sbracken
May 5, 2020 @ 10:39 am Blogs, Covid-19
Pfizer, with corporate offices in New York, and BioNTech (Biopharmaceutical New Technologies), headquartered in Germany, have announced they have begun human clinical trials for a COVID-19 vaccine in both the United States and Germany. In the United
AstraZeneca, a biopharmaceutical company headquartered in the United Kingdom, and the University of Oxford today announced they are working on a vaccine for the coronavirus which causes COVID-19. The vaccine is being developed by the The Edward
Posted By: Staff
April 30, 2020 @ 12:00 am News Daypop
Oxford University scientists who have already begun testing a potential coronavirus vaccine in humans say they believe that it might be available as early as September. The vaccine, which is being developed by the Jenner Institute and
A vaccine for COVID-19 may be available by the end of this year. Dr. Kizzmekia Corbett, a researcher with Dale and Betty Bumpers Vaccine Research Center, part of the National Institute of Allergy and Infectious Diseases (NIAID),
Two of the world’s largest vaccine manufacturers are joining forces to develop a new vaccine to prevent COVID-19. Sanofi and GlaxoSmithKline issued a joint press release announcing they intend to enter into a collaboration to develop an